D.E. Shaw & Co’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-5,106,072
| Closed | -$4.52M | – | 3842 |
|
|
2022
Q4 | $4.52M | Buy |
5,106,072
+49,109
| +1% | +$43.5K | 0.01% | 1526 |
|
|
2022
Q3 | $7.94M | Sell |
5,056,963
-824,439
| -14% | -$1.29M | 0.01% | 1063 |
|
|
2022
Q2 | $11.8M | Sell |
5,881,402
-1,360,489
| -19% | -$2.73M | 0.01% | 875 |
|
|
2022
Q1 | $16.9M | Buy |
7,241,891
+4,794,841
| +196% | +$11.2M | 0.02% | 786 |
|
|
2021
Q4 | $11.4M | Sell |
2,447,050
-505,785
| -17% | -$2.35M | 0.01% | 1037 |
|
|
2021
Q3 | $22.5M | Buy |
2,952,835
+1,142,466
| +63% | +$8.72M | 0.02% | 652 |
|
|
2021
Q2 | $17.5M | Buy |
1,810,369
+1,415,064
| +358% | +$13.7M | 0.02% | 776 |
|
|
2021
Q1 | $3.27M | Buy |
395,305
+62,967
| +19% | +$521K | ﹤0.01% | 1570 |
|
|
2020
Q4 | $2.27M | Sell |
332,338
-313,069
| -49% | -$2.14M | ﹤0.01% | 1679 |
|
|
2020
Q3 | $7.2M | Buy |
645,407
+512,169
| +384% | +$5.71M | 0.01% | 1027 |
|
|
2020
Q2 | $837K | Sell |
133,238
-69,281
| -34% | -$435K | ﹤0.01% | 1973 |
|
|
2020
Q1 | $373K | Sell |
202,519
-373,626
| -65% | -$688K | ﹤0.01% | 2256 |
|
|
2019
Q4 | $1.95M | Buy |
576,145
+503,174
| +690% | +$1.7M | ﹤0.01% | 1614 |
|
|
2019
Q3 | $156K | Buy |
+72,971
| New | +$156K | ﹤0.01% | 2425 |
|
|
2019
Q2 | – | Sell |
-68,126
| Closed | -$324K | – | 2799 |
|
|
2019
Q1 | $324K | Sell |
68,126
-825,874
| -92% | -$3.93M | ﹤0.01% | 2244 |
|
|
2018
Q4 | $2.15M | Buy |
894,000
+7,384
| +0.8% | +$17.7K | ﹤0.01% | 1495 |
|
|
2018
Q3 | $3.9M | Sell |
886,616
-126,207
| -12% | -$555K | ﹤0.01% | 1228 |
|
|
2018
Q2 | $7.29M | Buy |
1,012,823
+309,451
| +44% | +$2.23M | 0.01% | 951 |
|
|
2018
Q1 | $3.62M | Buy |
703,372
+692,372
| +6,294% | +$3.57M | ﹤0.01% | 1212 |
|
|
2017
Q4 | $42K | Buy |
+11,000
| New | +$42K | ﹤0.01% | 2485 |
|
|
2015
Q4 | – | Sell |
-48,972
| Closed | -$411K | – | 2814 |
|
|
2015
Q3 | $411K | Buy |
+48,972
| New | +$411K | ﹤0.01% | 2123 |
|